Background: The Polycystic Ovary Syndrome (PCOS) is the commonest endocrine disturbance affecting women, several complications of pregnancy in women with Polycystic Ovary Syndrome (PCOS) including recurrent pregnancy loss, the exact mechanisms that may cause RPL in PCOS patients are obscure. Several etiologies have been proposed, hyperhomocysteinemia is a common finding in women with PCOS and was found to be associated with both RPL and PCOS.
Introduction THE Polycystic Ovary Syndrome (PCOS) is the commonest endocrine disturbance affecting women and comprises a heterogeneous collection of signs
Correspondence to: Dr. Tarek M. El-Hawary, E-Mail: thawary4@yahoo.com and symptoms that gather together to form a spectrum of a disorder with a mild presentation in some women and a severe disturbance of reproductive, endocrine and metabolic function in others [1] .
A higher prevalence of several complications of pregnancy in women with Polycystic Ovary Syndrome (PCOS), compared with healthy mothers with no PCOS, has been described. These include an increased prevalence of spontaneous miscarriage, gestational diabetes, pre-eclamptic toxaemia and Pregnancy-Induced Hypertension (PIH) and the birth of Small-for-Gestational-Age (SGA) babies [1] .
Homocysteine is thought to exert a toxic effect on the haemostatic system perhaps indirectly by its effects on the endothelium through generation of hydrogen peroxides, depletion of nitric oxide mediated detoxification of homocysteine, and impairing endothelial cell thrombomodulin expression [2] . Increased thrombosis caused by Hhcy resulting micro thrombi formation in the vessel bed of placenta can impair sustained placental function. These micro thrombi may cause multiple placental infarctions and subsequently maternal complications of pregnancy [3] .
Hyperhomocysteinemia is a common finding in women with PCOS and was found to be associated with both RPL and PCOS [4] . It was shown that combined treatment with aspirin and Low Molecular Weight Heparin (LMWH) in women with hyperhomocysteinemia improved successful pregnancy rates [5] [6] [7] .
Patients and Methods
This is a randomized prospective comparative study was conducted on (120) pregnant women 195 have high level of homocystiene <15mmol/L in department of Obstetrics & Gynecology at Tanta University Hospital in a duration of one year from April 2017 to April 2018. All patients were undergoing the standard procedures of protocol. Women included in this study were classified into 3 groups:
Group I: Included 40 pregnant women diagnosed as polysystic ovary syndrome with high level of homocystiene <15mmol/L and suffered from recurrent pregnant loss and were treated with Low Dose Aspirin (LDA) 75mg dially.
Group II: This group included 40 pregnant women diagnosed as polysystic ovary syndrome with high level of homocystiene <15mmol/L and suffered from recurrent pregnant loss and were treated with low molecular weight heparin (clexane 40mg once dially).
Group III: This group included 40 pregnant women diagnosed as polysystic ovary syndrome with high level of homocystiene <15mmol/L and suffered from recurrent pregnant loss and were treated with Low Dose Aspirin (LDA) 75mg dially plus clexane 40mg once dially.
The inclusion criteria were:
• Age between 20 and 35 years old.
• Gestational age (till 20 weaks) calculated from the last menstrual period.
• Patients with PCO (PCOS was diagnosed according to the rotterdam criteria if at least two of the following criteria were present: Oligo / amenorrhoea, clinical or biochemical hyperandrogenism and PCO on Ultrasound (US).
• Patients with hyperhomocysteinemia (<15mmol/ L).
• Patients with recurrent pregnancy loss (two or more consecutive miscarriages).
The exclusion criteria were:
• Women with any systemic disease (hypertension, diabetes mellitus, renal or hepatic diseases) was ruled out by either physical examination or patient history.
• Women have other causes of RPL including chromosomal, uterine abnonnalities; anti phospholipid syndrome, inflammatory, autoimmune, and any other condition affecting homeostasis, was ruled out by either physical examination or patient history.
• Smokers and alcohol consumption.
All patients subjected to the following:
• An informed consent obtained from all participants in this research.
• Full history taking: -Personal history: Name, age, occupätion, residency and Special habits.
-Husband history: Name, age, occupätion, residency, special habits and diseases.
-Obestatric history: Gravidity, parity, gestational age.
-Past history: Medical diseases, abdominal surgeries, drug therapy or allergy.
-Menstrual history: Menarche, regularity, duration, amount and associated päin.
• General & local clinical examination:
To exclude general diseases, local causes of RPL.
• Measurement of homocysteine by ELISA.
• Drugs used for treatment: -LDA 75mg once dially used for patients in group I.
-LMWH 40mg once dially used for patients in group II.
-LDA 75mg once dially and LMWH 40mg once dially used for patients in group III.
• Follow-up all patients till pregnancy complete 20 weeks gestation to evaluate treatment effect in prophylaxis against early recurrent pregnancy loss in three groups.
Results
The present study was carried out on 120 pregnant women in reproductive period. They were classified into three groups: • Group I treated with low dose aspirin (40).
• Group II treated with low molecular weight heparin (40).
• Group III treated with low dose aspirin and low molecular weight heparin (40).
And followed them till the age of 20 weeks of gestation to evaluate the effect of these drugs in prevention of miscarriage.
Patient's age range in all groups between 20-35 years and there were other socio-demographic data which have no significant difference as gravidity, parity and BMI. There was no significant difference between age, gravidity, parity and BMI of patients of three groups. 
Discussion
The prevalence of PCO morphology among women with RPL is thought to be as high as 40%, although there are reports about higher prevalence. Using a combination of clinical findings and Ultrasound (US) or biochemical features [8, 9] .
The exact mechanisms that may cause RPL in PCOS patients are obscure. Several etiologies have been proposed, related to the pathophysiology, endocrinology, and metabolic disturbances in PCOS. Among these are obesity, insulin resistance or hyperinsulinemia, thrombophilia-associated disorders, elevated LH, and hyperandrogenism [10, 11] .
Homocysteine is thought to exert a toxic effect on the haemostatic system perhaps indirectly by its effects on the endothelium through generation of hydrogen peroxides, increased thrombosis caused by Hhcy resulting micro thrombi formation in the vessel bed of placenta can impair sustained placental function. These micro thrombi may cause multiple placental infarctions and subsequently maternal complications of pregnancy [12, 13] . Hyperhomocysteinemia is a common finding in women with PCOS [14] and was found to be associated with both RPL and PCOS [4] . It was shown that combined treatment with aspirin and Low Molecular Weight Heparin (LMWH) in women with hyperhomocysteinemia improved successful pregnancy rates [5] [6] [7] .
The present study aimed to detect prophylactic effect of low dose aspirin and low molecular weight heparin against early recurrent pregnancy loss in patients with PCOS and hyperhomocystenemia.
It was carried out on 120 pregnant women in reproductive period. There were classified into three groups: Group one womens treated with Low Dose Aspirin (LDA) 75mg once dially (40 women). Group two women treated with LMWH 40mg once dially (40 women). Group three womens treated with LDA and LMWH.
This study included women age ranged between 20-35, 20-34 and 20.5-35 years with mean of 28.88 ± 4.85, 27.33 ±3.79 and 28.48 ±4.21 years for group 1, group 2 and group 3 respectively. Ther was no statistical significant difference between three groups regarding age. The included women in this study were with BMI ranged between 19-32, 19-32 and 19-31 with mean of 25.68 ±3.85, 26.23±3.91 and 25.45 ±3.65 for group 1, group 2 and group 3 respectively. Ther was no statistical significant difference between three groups regarding BMI.
In the present study serum fasting homocyseine level ranged between 15-25, 15.2-25 and 15-25 Umol/l with mean of 20.28±2.09, 20.08±3.20 and 19.43 ± 2.82 for group 1, group 2 and group 3 respectively. Homocyseine level is high in three groups, there was no statistical significant difference between three groups regarding homocyseine level lastly.
The use of clexan or Clexan with LDA prevent early recurrent pregnancy loss in patients with PCOS and hyperhomocysteinemia are better than LDA alone.
Conclusion:
The use of clexane or Clexane with LDA prevent early recurrent pregnancy loss in patients with PCOS and hyperhomocysteinemia better than LDA alone.
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